Related Experiment Videos
Alopecia due to psychotropic medications
1The Clarke Institute of Psychiatry, University of Toronto, Ontario, Canada. monica.gautam@utoronto.ca
The Annals of Pharmacotherapy
|June 16, 1999
Summary
Psychotropic drug-induced hair loss is uncommon but can affect compliance. Discontinuing the medication usually resolves alopecia, aiding therapeutic success.
Area of Science:
- Pharmacology and Dermatology
- Adverse Drug Reactions
- Psychiatric Medication Side Effects
Background:
- Alopecia, or hair loss, is a potential adverse effect of psychotropic medications.
- Understanding the incidence and nature of this side effect is crucial for clinical management.
- Patient perception and compliance are significantly impacted by drug-induced hair loss.
Purpose of the Study:
- To review existing literature on psychotropic drug-related alopecia.
- To describe the incidence and characteristics of this adverse event.
- To guide clinicians in therapeutic decision-making when alopecia occurs.
Main Methods:
- Comprehensive literature search of MEDLINE (1966-1998) and other databases.
- Inclusion of published case reports and review articles.
- Data extraction focused on drug therapy, alopecia development, and clinical outcomes.
Main Results:
- Hair loss (scalp, eyebrows, pubic area) is an uncommon adverse effect of most psychotropic drugs.
- Discontinuation of the offending medication led to resolution in nearly all reported cases.
- Patients often perceive alopecia negatively, leading to poor compliance and treatment failure.
Conclusions:
- Mild to moderate hair loss may be managed by continuing therapy if clinically beneficial and patient-consented.
- Severe alopecia warrants medication discontinuation and switching to an alternative agent.
- Effective management of alopecia is key to positive therapeutic outcomes and improved patient compliance.